# OnCo record radicals-hd (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/radicals-hd/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "radicals-hd", "ISRCTN40814031" ;
  schema:name "RADICALS-HD"@en ;
  schema:alternateName "RADICALS-HD"@en, "RADICALS hormone duration comparison"@en ;
  schema:description "Two years of hormone therapy alongside radiotherapy after prostate surgery kept the cancer from spreading in six more men in a hundred than six months did, at the cost of more side effects."@en ;
  schema:url <https://onco.cc/trials/radicals-hd/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00541047>, <https://www.isrctn.com/ISRCTN40814031>, <https://doi.org/10.1016/S0140-6736(24)00549-X> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/bicalutamide/>, <https://onco.cc/drugs/degarelix/> ;
  onco:companies <https://onco.cc/companies/mrc-ctu/> ;
  onco:institutions <https://onco.cc/institutions/uclh/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/salvage-therapy/>, <https://onco.cc/terms/prostatectomy/>, <https://onco.cc/terms/hormone-therapy/> ;
  onco:trials <https://onco.cc/trials/radicals-rt/>, <https://onco.cc/trials/getug-afu-16/>, <https://onco.cc/trials/nct00567580/> .